UMD Catalyst Grant: Maaike Oosterveer
Liver disease, in particular hepatic tumorigenesis, represent a serious long-term complication in adult patients suffering from Glycogen Storage Disease type 1a (GSD Ia). Current dietary management primarily aims to prevent life-threatening hypoglycemia, and does generally not prevent liver disease. It is therefore critical to explore novel therapeutic strategies.
In this collaborative and preclinical research project Dr. Maaike Oosterveer (UMCG Laboratory of Pediatrics) and Prof. Dr. Riekelt Houtkooper (AMC Laboratory of Genetic Metabolic Diseases) will investigate the impact of dietary supplementation on development of liver disease in GSD Ia.
https://www.unitedformetabolicdiseases.nl/english/home.html
| Last modified: | 21 September 2020 11.08 a.m. |
More news
-
12 October 2020
‘We have every faith in the creativity and resilience of our University’ - Interview Board of the University
The COVID-19 restrictions have been tightened once again. To many staff members and students, this feels like a step backwards. We chatted with members of the Board of the University Jouke de Vries, Cisca Wijmenga and Hans Biemans about managerial...
-
08 October 2020
Olympic athletes should be mindful of their biological clocks
Biological clocks have sizeable effects on the performance of elite athletes. This conclusion was drawn by chronobiologists from the University of Groningen after studying the times achieved by swimmers in four different Olympic Games. Shifting the...
-
29 September 2020
Oscar Couwenberg appointed Honorary Professor at the UG/Campus Fryslân
Professor Oscar Couwenberg was appointed Honorary Professor of Corporate Governance at the University of Groningen/Campus Fryslân. Couwenberg was previously the Dean of the Faculty of Spatial Sciences of the University of Groningen and is currently...